106 related articles for article (PubMed ID: 32135634)
1. [The effects of cyclophosphamide binding mesenchymal stem cells on IFN-γ induced 32D cells apoptosis and its mechanism].
Wang L; Mu H; Lin ZH; Zhang LL; Xu Y; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):157-160. PubMed ID: 32135634
[No Abstract] [Full Text] [Related]
2. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
[TBL] [Abstract][Full Text] [Related]
3. [The Effects of IFN-γ on AKT activated 32D Cells and its Mechanisms].
Tong LG; Liu H; Lin ZH; Li JH; Jiang SH; Chen XF; Huang HM; Lu W; Zhou L
Zhonghua Xue Ye Xue Za Zhi; 2010 Dec; 31(12):826-9. PubMed ID: 21223740
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma attenuates the survival activity of G-CSF through PI3K/Akt signaling pathway in mouse multipotent progenitor cells.
Liu H; Mihara K; Song G; Tanaka H; Kimura A
Ann Hematol; 2007 Aug; 86(8):547-55. PubMed ID: 17549474
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ stimulation of dental follicle mesenchymal stem cells modulates immune response of CD4
Genç D; Zibandeh N; Nain E; Arığ Ü; Göker K; Aydıner EK; Akkoç T
Allergol Immunopathol (Madr); 2019; 47(5):467-476. PubMed ID: 30826066
[TBL] [Abstract][Full Text] [Related]
8. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
10. Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells.
Goedhart M; Cornelissen AS; Kuijk C; Geerman S; Kleijer M; van Buul JD; Huveneers S; Raaijmakers MHGP; Young HA; Wolkers MC; Voermans C; Nolte MA
Stem Cells Dev; 2018 May; 27(9):579-589. PubMed ID: 29649408
[TBL] [Abstract][Full Text] [Related]
11. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.
Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J
Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812
[TBL] [Abstract][Full Text] [Related]
12. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level.
Wang W; Guo H; Li H; Yan Y; Wu C; Wang X; He X; Zhao N
Hum Gene Ther; 2018 Feb; 29(2):234-241. PubMed ID: 29054137
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells.
Sekiya M; Adachi M; Takayama S; Reed JC; Imai K
Biochem Biophys Res Commun; 1997 Oct; 239(2):401-6. PubMed ID: 9344841
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
[TBL] [Abstract][Full Text] [Related]
16. Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells.
Miller JH; Rouwé B; Gaitanos TN; Hood KA; Crume KP; Bäckström BT; La Flamme AC; Berridge MV; Northcote PT
Apoptosis; 2004 Nov; 9(6):785-96. PubMed ID: 15505421
[TBL] [Abstract][Full Text] [Related]
17. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge.
Chan WK; Lau AS; Li JC; Law HK; Lau YL; Chan GC
Exp Hematol; 2008 Nov; 36(11):1545-55. PubMed ID: 18715686
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead.
Carvalho AÉS; Sousa MRR; Alencar-Silva T; Carvalho JL; Saldanha-Araujo F
Cytokine Growth Factor Rev; 2019 Jun; 47():32-42. PubMed ID: 31129018
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells.
Beppu K; Morisaki T; Matsunaga H; Uchiyama A; Ihara E; Hirano K; Kanaide H; Tanaka M; Katano M
Biochem Biophys Res Commun; 2003 Jun; 305(4):797-805. PubMed ID: 12767900
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
